This inventor holds 1 USPTO granted patent and 9 published patent applications. Top assignee: Quelltx, Inc.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Innovations in Pain Management: The Contributions of Caitlin Lewarch
Introduction
Caitlin Lewarch is an innovative inventor based in Cambridge, MA (US). She has made significant strides in the field of pain management through her groundbreaking research and development of non-opioid therapeutic compositions. Her work aims to provide effective alternatives for pain relief without the risks associated with opioid medications.
Latest Patents
Caitlin Lewarch holds a patent for her invention titled "Therapeutic compositions for treating pain via multiple targets." This invention provides non-opioid pain therapeutic compositions that include an antisense oligonucleotide (ASO) complementary to an identified target on a NaV channel mRNA. The ASO hybridizes to its target RNA and forms a duplex that recruits RNase H to degrade the RNA, thereby downregulating NaV channel synthesis. This process inhibits the neuron's ability to contribute to the perception of pain. The ASO targets one of the specific identified targets and may be provided as a gapmer that includes a central DNA segment flanked by modified RNA wings. When the composition is delivered to dorsal root ganglion (DRG) neurons in vitro, the DRG neurons exhibit a dose-dependent knockdown of NaV1.7, NaV1.8, or NaV1.9.
Career Highlights
Caitlin is currently associated with Quelltx, Inc., where she continues to advance her research in pain management. Her innovative approach has the potential to revolutionize how pain is treated, providing safer and more effective options for patients.
Collaborations
Caitlin collaborates with talented individuals such as Owen McManus and Dawei Zhang, who contribute to her research efforts and help bring her innovative ideas to fruition.
Conclusion
Caitlin Lewarch's contributions to the field of pain management through her innovative patent demonstrate her commitment to improving patient care. Her work exemplifies the potential of non-opioid therapies in addressing pain effectively and safely.